2013
DOI: 10.1124/mol.112.084582
|View full text |Cite
|
Sign up to set email alerts
|

Repressive Epigenetic Changes at themGlu2Promoter in Frontal Cortex of 5-HT2AKnockout Mice

Abstract: Serotonin 5-HT 2A and metabotropic glutamate 2 (mGlu2) are G protein-coupled receptors suspected in the pathophysiology of psychiatric disorders, such as schizophrenia, depression, and suicide. Previous findings demonstrate that mGlu2 mRNA expression is down-regulated in brain cortical regions of 5-HT 2A knockout (KO) mice. However, the molecular mechanism responsible for this alteration remains unknown. We show here repressive epigenetic changes at the promoter region of the mGlu2 gene in frontal cortex of 5-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
28
0

Year Published

2014
2014
2018
2018

Publication Types

Select...
7
3

Relationship

2
8

Authors

Journals

citations
Cited by 32 publications
(28 citation statements)
references
References 52 publications
0
28
0
Order By: Relevance
“…Antibodies were screened by assessing enrichment of the constitutively active gene, β-actin , over the neuronally repressed gene, ε-globin ; there was no difference in enrichment between EtOH and saline treated animals (Fig. S1) (Kurita et al, 2013). Antibodies were also validated by assessing binding to peptide arrays containing 46 histone modifications to the H3 N-terminal tail (Millipore #16-667); H3K27me3 and H3K4me3 antibodies bound to their stated histone modifications while the H3K9,14ac antibody bound H3K9ac but not H3K14ac (data not shown).…”
Section: Methodsmentioning
confidence: 99%
“…Antibodies were screened by assessing enrichment of the constitutively active gene, β-actin , over the neuronally repressed gene, ε-globin ; there was no difference in enrichment between EtOH and saline treated animals (Fig. S1) (Kurita et al, 2013). Antibodies were also validated by assessing binding to peptide arrays containing 46 histone modifications to the H3 N-terminal tail (Millipore #16-667); H3K27me3 and H3K4me3 antibodies bound to their stated histone modifications while the H3K9,14ac antibody bound H3K9ac but not H3K14ac (data not shown).…”
Section: Methodsmentioning
confidence: 99%
“…While HTR2A receptor mediated these effects (HT2RA null mutant mice exhibit no change), HDAC inhibitors could inhibit these GRM2 modifications as well as the effects of atypical antipsychotics in mice [121]. A disrupted HTR2A signaling may also lead to reduced activation of Egr1 (early growth response 1) promoter, and a decrease in H3 and H4 acetylation, and an increase in the level of H3K27 me3 at the promoter region of GRM2 suppressing its expression [122]. Meanwhile, the clozapine-induced chromatin modifications of GAD1 and RELN promoters can be augmented by HDAC inhibitors such as valproate, which are not dependent upon the status of catecholamine or serotonin receptors [123].…”
Section: Therapeutic Agents That Modulate Histone Codesmentioning
confidence: 96%
“…The mGlu2 receptors are G protein-coupled receptors that form covalently linked homodimers (Pin et al, 2003). Here, we measured mGlu2 IR as a monomer (Kurita et al, 2013) …”
Section: A C C E P T E D Accepted Manuscriptmentioning
confidence: 99%